Identification of Plasma Metabolomic Profiling for Diagnosis of Esophageal Squamous-Cell Carcinoma Using an UPLC/TOF/MS Platform
Open Access
- 24 April 2013
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 14 (5), 8899-8911
- https://doi.org/10.3390/ijms14058899
Abstract
Epidemiological studies indicated that esophageal squamous-cell carcinoma (ESCC) is still one of the most common causes of cancer incidence in the world. Searching for valuable markers including circulating endogenous metabolites associated with the risk of esophageal cancer, is extremely important A comparative metabolomics study was performed by using ultraperformance liquid chromatography-electrospray ionization-accurate mass time-of-flight mass spectrometry to analyze 53 pairs of plasma samples from ESCC patients and healthy controls recruited in Huaian, China. The result identified a metabolomic profiling of plasma including 25 upregulated metabolites and five downregulated metabolites, for early diagnosis of ESCC. With a database-based verification protocol, 11 molecules were identified, and six upregulated molecules of interest in ESCC were found to belong to phospholipids as follows: phosphatidylserine, phosphatidic acid, phosphatidyl choline, phosphatidylinositol, phosphatidyl ethanolamine, and sphinganine 1-phosphate. Clinical estimation of metabolic biomarkers through hierarchical cluster analysis in plasma samples from 17 ESCC patients and 29 healthy volunteers indicated that the present metabolite profile could distinguish ESCC patients from healthy individuals. The cluster of aberrant expression of these metabolites in ESCC indicates the critical role of phospholipid metabolism in the oncogenesis of ESCC and suggests its potential ability to assess the risk of ESCC development in addition to currently used risk factors.This publication has 41 references indexed in Scilit:
- Challenges and opportunities of metabolomicsJournal of Cellular Physiology, 2011
- Lipidomic approach to identify patterns in phospholipid profiles and define class differences in mammary epithelial and breast cancer cellsBreast Cancer Research and Treatment, 2011
- Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug ResistanceFuture Oncology, 2010
- Advances in structure elucidation of small molecules using mass spectrometryBioanalytical Reviews, 2010
- Worldwide esophageal cancer collaborationDiseases of the Esophagus, 2009
- Metabolomic profiles delineate potential role for sarcosine in prostate cancer progressionNature, 2009
- HMDB: a knowledgebase for the human metabolomeNucleic Acids Research, 2008
- S1P differentially regulates migration of human ovarian cancer and human ovarian surface epithelial cellsMolecular Cancer Therapeutics, 2008
- Principles of bioactive lipid signalling: lessons from sphingolipidsNature Reviews Molecular Cell Biology, 2008
- MetabolomicsCell Metabolism, 2007